INTRODUCTION P
latelets and lipoproteins are intimately in.vOlved in the pathogenesis of a wide variety of diseases, including atherosclerosis and thrombosis. Accumulating evidence suggests the possibility of a direct relationship between plasma lipoproteins and the hemostatic function of platelets. Reports of abnormal platelet / function in patients with familial hypercholesterolemia (FH) are particularly pertinent in this regard. Platelets from patients with FH exhibit enhanced aggregation to a variety of physiological stimuli, as well as an increased cholesterol and phospholipid contento I Therefore, the lipid content may provide a basis for the abnormalities of platelet function observed in this disease.
CASE REPORT
The patient was a 27-year-old female with a diagnosis of familial hypercholesterolemia based on clinicaI and biochemical criteria. She was on a low-lipid diet, and lipidlowering drugs were stopped one month before the start of the study. The protocol of the study was approved by the Institutional Board, and the patient was fully informed. Plasma exchange was performed in this patient once a week when the plasma lipid values were high again, on an outpatient basis. Selective low-density lipoprotein (LDL)-.apheresis was performed using DSC columns (LipoSorber, Kanegafushi, Chemical Industrial Co. Ltd., Osaka, Japan). Plasma exchange had already been performed before the experiment: 114 procedures (3 times/week) folIowed by 31 procedures (once a week). Before the first LDLapheresis procedure, plasma readings were as folIows: total cholesterol (506 mg/dl), triglycerides (183 mg/dl), HDLcholesterol (39 mg/dl), LDL-cholesterol (432 mg/dl), VLDL-cholesterol (33 mg/dl) and apo B (2.85 g/l).
Blood was drawn just before the plasmapheresis procedures, initiated after 14 hr of fasting, and then immediately afterwards. For lipid studies, blood samples were colIected on EDTA (lmg/ml), and plasma obtained by low-speed centrifugation. Total cholesterol (TC) and triglycerides (TG) were measured by enzymatic methods. HDL-cholesterol (HDL-C) was measured with the same method after precipitation of LDL and VLDL with MgCl 2 and phosphotungstic acid. VLDL-cholesterol (V~DL-C) was calculated assuming the relation VLDL = TG/5, and LDL-cholesterol (LDL-C) was estimated according to Friedwald's equation. Plasma apolypoproteins A, AI' and B were determined by radial immunodiffusion.
For platelet aggregation studies, blood was colIected in 3.8 percent sodium citrate (1: 10) just before and immediately' after plasmapheresis procedures. Platelet aggregation was studied in whole blood using an impedance aggregometer. The curve amplitude was calculated 5 min after the aggregation. ADP(Sigma Chemical Co., S1. Louis,-MO, USA) was used as the aggregating agen1. Platelet-rich plasma (PRP) was obtained by centrifugation at 200g for 10 min at room temperature. Platelet aggregation in PRP was measured in a photometric aggregometer. Platelet concentrations were mainly in the range 4.20-4.45 x 10 5 /ml. Adrenaline, ADP and thrombin (alI from Sigma) were used as aggregating agents.
Washed platelets were obtained after adjusting the pH of the PRP to 6.5 with citric acid and platelet sedimentation by centrifugation at I,600g for 10 minoThe platelets were resuspended and washed in citrate wash buffer supplemented with 0.35 percent bovine serum albumin (fraction V, Sigma). After 3 washes, the platelets were resuspended in a modified Tyrode's buffer (136 mmolll NaCI; 5.5 mmolll glucose; 2.7 mmol/l KCl; 0.07 mmol/l Na 2 HP0 4 ; 0.01 mmol/l NaHC0 3 , pH7.4). Thrombin was used as aggregating agen1.Washed platelet aggregation was performed as described for PRP.
The values for plasma lipids in the patient correspond with values previously obtained in defining this disease. Changes in plasma lipids, lipoproteins and apolipoproteins, immediately after LDL-apheresis, are reported in Table 1 . AlI measured lipid classes, with the exception of HDL-C, decreased. The procedure was more selective to remove apo B-containing lipoproteins. The main decrements were found for total cholesterol, triglycerides, LDL-C, VLDL-C and apo B (around 71, 68, 79, 65, and 80 percent, respectively).
In Table 2 , the effect of LDL-apheresis on whole blood platelet aggregation can be seen. Removal of lipids In this patient, selective LDL-apheresis allowed the removal of close to 70 percent of plasma cholesterol and
Results are expressed as means :t SEM trom 3 ditterent LDLapheresis procedures. * p < 0.05 triglycerides. The procedure also decreased LDL-C and VLDL-C by 80 and 65 percent, respectively, without changing the plasma content of HDL-C. Apo-B leveIs also dramatically dropped by 80 percent.
The effect of the lipoprotein plasma concentration on the function of circulating platelets becomes of importance in the light of accumulating evidence that hyperlipidemia, platelet function and thrombosis are interrelated. We have observed, in this patient, that platelet aggregation in whole blood as well as in PRP, decreased immediately after LDL-apheresis. Moreover, maximum aggregation leveIs were obtained, before the treatment, with lower concentrations of aggregating agents.
LDL is known to influence platelet reactivity. It was shown that platelets separated from their plasma milieu and incubated briefly with isolated LDL at concentrations within the physiological range are rapidly sensitized; at higher concentrations, LDL particles as well as cholesterolrich liposomes act as agonists themselves, with stimulation of phosphatidylinositol and TXB2 formation, similarly to other platelet activators.
1 The possibility that LDL changes the reactivity of platelets by influencing the cholesterol/ phospholipid ratio of the membrane is a strong explanation for the observed effects.
FH-derived platelets have been shown to contain more cholesterol thannormal platelets, and it has been suggested that the platelet hyperacti vity observed in FH patients is a consequence of their increased cholesterol content, which in turn is dependent on the cholesterol concentration of the platelet plasma environment. This is substantiated by studies in which labeled LDL binding to platelets was decreased when the platelets were suspended in plasma, as consequence of saturated non-Iabeled LDL. 2 Platelets from FH patients have been described as having increased aggregation whether as PRP or as plasma-free-gel-filtered platelets, which has been taken to indicate a change in the platelets induced by abnormal plasma constituents. On the other hand, it was shown that aggregation of washed platelets from patients with FH decreased to the low normal range. 2 Plasma exchange in patients with hypercholesterolemia was described to have a beneficiaI effect on platelet function in vitro;3 however, in that study, the plasma exchange technique used was probably not selective for apo B-containing particles. 3 In contrast to these positive data, it has been shown that the enhanced in vitro sensitivity of platelets from FH patients to a variety of aggregating agents did not change after a single, as well as regular removal of plasma cholesterol by LDL-apheresis;4 however, in these reports, platelet studies were performed two days after the apheresis procedure, when plasma cholesterol concentration was again at a high leveI. (Table 3) , as well as by adrenaline and thrombin (data not shown). Moreover, maximum aggregation was obtained, before LDL-apheresis procedure, with lower concentrations of aggregatory agents, when compared to post-apheresis platelet aggregation.
The effects of LDL-apheresis on the aggregation of washed platelets induced by thrombin are shown in Table 4 . LDL-apheresis did not affect aggregation in washed platelets. 
